<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235742</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32212</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet B Neuropsychiatr Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. B Neuropsychiatr. Genet.</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4841</issn>
<issn pub-type="epub">1552-485X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26756273</article-id>
<article-id pub-id-type="pmc">5154859</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.b.32413</article-id>
<article-id pub-id-type="manuscript">NIHMS833984</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetics of Psychosis of Alzheimer Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shah</surname>
<given-names>Chintan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>DeMichele-Sweet</surname>
<given-names>Mary Ann A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sweet</surname>
<given-names>Robert A.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania</aff>
<aff id="A2"><label>2</label>Department of Psychiatry and Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania</aff>
<aff id="A3"><label>3</label>VISN 4 Mental Health Illness Research, Education and Clinical Center (MIRECC), VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence to: Robert A. Sweet, M.D., Department of Psychiatry and Neurology, University of Pittsburgh, Pittsburgh, PA 15213. <email>sweetra@upmc.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2017</year>
</pub-date>
<volume>174</volume>
<issue>1</issue>
<fpage>27</fpage>
<lpage>35</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.b.32413-->
<abstract>
<p id="P1">Psychotic symptoms, comprised of delusions and hallucinations, occur in about half of individuals with Alzheimer disease (AD with psychosis, AD+P). These individuals have greater agitation, aggression, depression, functional impairment, and mortality than individuals without psychosis (ADâˆ’P). Although the exact etiopathogenesis of AD+P is unclear, the rapidly developing field of genomics continues to expand our understanding of this disease. Several independent studies have demonstrated familial aggregation and heritability of AD+P. Linkage studies have been suggestive of loci on several chromosomes associated with AD+P. Association studies examining apolipoprotein E gene, the best established genetic risk factor for late-onset AD, did not find any significant association of this gene with AD+P. Other candidate gene studies focusing on monoamine neurotransmitter systems have yielded equivocal results. A genome-wide association study and studies examining copy number variations recently have detected suggestive associations, but have been underpowered. Approaches to increase sizes of AD+P samples for genome wide association studies are discussed.</p>
</abstract>
<kwd-group>
<kwd>Alzheimer disease</kwd>
<kwd>psychosis</kwd>
<kwd>genome-wide association</kwd>
<kwd>heritability</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>